Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021
Corporate Participants:
Christopher DelOrefice — Vice President, Investor Relations
Joseph J. Wolk — Executive Vice President, Chief Financial Officer
Jennifer Taubert — Executive Vice President, Worldwide Chairman, Pharmaceuticals
Thibaut Mongon — Executive Vice President, Worldwide Chairman, Consumer Health
Ashley McEvoy — Executive Vice President, Worldwide Chairman, Medical Devices
Paul Stoffels — Vice Chairman of the Executive Committee and Chief Scientific Officer
Analysts:
Louise Chen — Cantor Fitzgerald Securities — Analyst
Larry Biegelsen — Wells Fargo Securities LLC — Analyst
Chris Schott — J.P. Morgan Securities LLC — Analyst
Bob Hopkins — BofA Securities, Inc. — Analyst
Joshua Jennings — Cowen and Company — Analyst
Terence Flynn — Goldman Sachs & Co. LLC — Analyst
Matt Miksic — Credit Suisse Securities (USA) LLC — Analyst
Joanne Wuensch — Citi — Analyst
Jayson Bedford — Raymond James Financial Inc. — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
KMI Earnings: Kinder Morgan reports financial results for Q3 2024
Energy infrastructure company Kinder Morgan, Inc. (NYSE: KMI) on Wednesday reported financial results for the third quarter of 2024. Net income, adjusted for special items, remained unchanged year-over-year at $0.25
Earnings Preview: General Motors’ Q3 results likely to benefit from EV growth
General Motors Co. (NYSE: GM) is expected to report its third-quarter results on October 22. The company is working towards the goal of achieving operating profit in its rapidly growing
What to expect when Philip Morris (PM) reports Q3 2024 earnings results
Shares of Philip Morris International Inc. (NYSE: PM) stayed green on Wednesday. The stock has gained 11% over the past three months. The tobacco giant is scheduled to report its